H Venning

<i>HLA-DRB1*11</i> and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis

Michael J. Ombrello, Elaine F. Remmers, Ioanna Tachmazidou et al. · Proceedings of the National Academy of Sciences · 2015 · 185 citations · Full text

Life Sciences, Genetics, Immunology +17

The Pediatric Rheumatology International Trials Organization criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus: Prospective validation of the disease activity core set

Nicolino Ruperto, Angelo Ravelli, Rubén Cuttica et al. · Arthritis & Rheumatism · 2005 · 103 citations

Medicine, Clinical Sciences, Pediatrics +17

The British version of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ).

Joshua R. Nugent, Nicolino Ruperto, John D. Grainger et al. · PubMed · 2002 · 74 citations

Medicine, Child Health, Pediatrics +16

Duration of etanercept treatment and reasons for discontinuation in a cohort of juvenile idiopathic arthritis patients

T Southwood, HE Foster, J Davidson et al. · Lara D. Veeken · 2010 · 72 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +14

Genetic susceptibility to early onset pauciarticular juvenile chronic arthritis: a study of HLA and complement markers in 158 British patients.

P J Hall, Sriti Burman, Marion Laurent et al. · Annals of the Rheumatic Diseases · 1986 · 58 citations

Life Sciences, Genetics, Immunology +17